Skip to content

Application of ultrasound-guided thoracic paravertebral block in breast cancer surgery

Application of ultrasound-guided thoracic paravertebral block in breast cancer surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039466
Enrollment
Unknown
Registered
2020-10-28
Start date
2020-11-02
Completion date
Unknown
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Tgroup:Ultrasound-guided thoracic paravertebral block
Sgroup:Pseudothoracic paravertebral block

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Aged 30-55 years; 2. ASA grade I ~ II; 3. Body Mass Index (BMI) 18-30 kg/m2; 4. TNM stage: T1-3N0-3m0; 5. Unilateral elective radical mastectomy is proposed; 6. Agreed to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindication of thoracic paravertebral blockade: abnormal coagulation function, puncture site infection, local anesthetic allergy, etc.; 2. Previous breast cancer surgery (excluding needle aspiration cytology biopsy) or a history of chronic pain; 3. Inflammatory breast cancer; He/she has a history of other cancers or other tumor surgery; 4. Antihistamine or analgesic or sedative drugs were used 24 h before operation; 5. Long-term history of opioid or antiemetic use; 6. Cannot cooperate with researchers for any reason: hearing or vision impairment, language comprehension impairment, mental illness, etc.; 7. Preoperative blood routine shows obvious abnormal lymphocyte or with other damage to the immune system diseases (such as: leukemia, autoimmune disease, immunodeficiency disease, etc.) or long-term use of immunosuppressive patients; 8. Men and pregnant women; 9. Pet-x is associated with central neuropathy, hepatic and renal dysfunction and hypotension (systolic pressure <= 90 mmHg). 10. The corpse has joined other researchers.

Design outcomes

Primary

MeasureTime frame
Postoperative first rescue analgesia time;Postoperative NLR count;

Countries

China

Contacts

Public ContactMing Xia
xiaming1980@xzhmu.edu.cn+86 15021306970

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026